Invention Grant
- Patent Title: Detection of angiopoietin-2 and thrombospondin-2 in connection with diagnosing acute heart failure
-
Application No.: US16045465Application Date: 2018-07-25
-
Publication No.: US11079394B2Publication Date: 2021-08-03
- Inventor: Thomas J. Wang , Deepak K. Gupta , Quinn S. Wells , Robert E. Gerszten
- Applicant: Vanderbilt University , Beth Israel Deaconess Medical Center, Inc.
- Applicant Address: US TN Nashville; US MA Boston
- Assignee: Vanderbilt University,Beth Israel Deaconess Medical Center, Inc.
- Current Assignee: Vanderbilt University,Beth Israel Deaconess Medical Center, Inc.
- Current Assignee Address: US TN Nashville; US MA Boston
- Agency: Stites & Harbison PLLC
- Agent Mandy Wilson Decker
- Main IPC: G01N33/68
- IPC: G01N33/68
Abstract:
Methods for detecting angiopoietin-2 (Angpt-2) and/or thrombospondin-2 (Tsp-2) in a sample involve obtaining or having obtained a blood or plasma sample from a subject; and detecting Angpt-2 and Tsp-2 in the sample. Detecting can involve performing an assay to determine whether the sample includes Angpt-2 and/or Tsp-2 or elevated levels of Angpt-2 and/or Tsp-2. Elevated levels are indicative of acute heart failure.
Public/Granted literature
- US20190033323A1 DETECTION OF ANGIOPOIETIN-2 AND THROMBOSPONDIN-2 IN CONNECTION WITH DIAGNOSING ACUTE HEART FAILURE Public/Granted day:2019-01-31
Information query
IPC分类:
